• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

休克期间猪体内组织型纤溶酶原激活物和纤溶酶原激活物抑制剂随时间向循环系统的释放情况。

Time dependent release of tissue-type plasminogen activator and plasminogen activator inhibitor into the circulation of pigs during shock.

作者信息

Siebeck M, Spannagl M, Hoffmann H, Schramm W, Fritz H

机构信息

Department of Surgery, Klinikum Innenstadt, University of Munich, Germany.

出版信息

Blood Coagul Fibrinolysis. 1991 Jun;2(3):459-64. doi: 10.1097/00001721-199106000-00009.

DOI:10.1097/00001721-199106000-00009
PMID:1834237
Abstract

To investigate short-term activation and inhibition of fibrinolysis during shock, we studied plasma levels of tissue-type plasminogen activator (t-PA) and t-PA inhibition capacity (PAI) in anaesthetized pigs. t-PA in euglobulin fractions of plasma was measured by the conversion of plasminogen to plasmin in the presence of fibrin split products. Plasmin thus generated was measured in a chromogenic substrate assay. PAI was measured as plasma inhibition capacity for human melanoma t-PA. Controls (n = 8) had constant t-PA and PAI for 6 h. Lipopolysaccharide from Salmonella abortus equi in four different doses (n = 9 - 11), or live Escherichia coli (n = 3) induced a transient t-PA increase with peak values at 2 h. PAI decreased to 50% at 2 h and increased to 250% at 6 h. Phorbol myristate acetate (n = 7) induced no change of t-PA or PAI. Dextran sulphate (n = 4) produced a t-PA rise at 30 min, followed by a rapid decline. Endotoxin was an appropriate stimulus for activation and inhibition of fibrinolysis whereas phorbol ester failed to elicit this response.

摘要

为研究休克期间纤维蛋白溶解的短期激活和抑制情况,我们对麻醉猪的血浆组织型纤溶酶原激活物(t-PA)水平和t-PA抑制能力(PAI)进行了研究。血浆优球蛋白组分中的t-PA通过在纤维蛋白降解产物存在的情况下将纤溶酶原转化为纤溶酶来测定。如此产生的纤溶酶在显色底物测定中进行测量。PAI作为对人黑色素瘤t-PA的血浆抑制能力进行测量。对照组(n = 8)在6小时内t-PA和PAI保持恒定。四种不同剂量(n = 9 - 11)的马流产沙门氏菌脂多糖或活大肠杆菌(n = 3)诱导t-PA短暂升高,峰值出现在2小时。PAI在2小时时降至50%,在6小时时升至250%。佛波酯肉豆蔻酸酯(n = 7)未引起t-PA或PAI的变化。硫酸葡聚糖(n = 4)在30分钟时使t-PA升高,随后迅速下降。内毒素是激活和抑制纤维蛋白溶解的合适刺激物,而佛波酯未能引发这种反应。

相似文献

1
Time dependent release of tissue-type plasminogen activator and plasminogen activator inhibitor into the circulation of pigs during shock.休克期间猪体内组织型纤溶酶原激活物和纤溶酶原激活物抑制剂随时间向循环系统的释放情况。
Blood Coagul Fibrinolysis. 1991 Jun;2(3):459-64. doi: 10.1097/00001721-199106000-00009.
2
Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.人类肿瘤坏死因子输注期间纤维蛋白溶解的进展。组织型纤溶酶原激活物、1型纤溶酶原激活物抑制剂和纤维蛋白(原)降解产物同时增加。
Blood. 1990 Dec 1;76(11):2284-9.
3
Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes.阿司匹林对组织型纤溶酶原激活物活性的体内抑制作用及其与组织型纤溶酶原激活物抑制剂抗原、纤溶酶原激活物及其复合物水平的关系。
Blood. 1989 Oct;74(5):1635-43.
4
Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.冠状动脉疾病患者运动期间纤溶酶原激活物抑制剂1和组织型纤溶酶原激活物的变化。
Haemostasis. 1990;20(5):305-12. doi: 10.1159/000216142.
5
Newborn's fibrinolytic mechanism: components and plasmin generation.
Am J Hematol. 1989 Dec;32(4):273-8. doi: 10.1002/ajh.2830320407.
6
Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.人肾小球系膜细胞对纤溶酶原激活物抑制剂1和组织型纤溶酶原激活物释放的细胞特异性调节。
Biochim Biophys Acta. 1992 Apr 7;1134(3):189-96. doi: 10.1016/0167-4889(92)90175-b.
7
Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.经尿道前列腺切除术患者血液纤溶与术中或术后即刻失血之间缺乏相关性。
Br J Urol. 1997 Jul;80(1):105-10. doi: 10.1046/j.1464-410x.1997.00251.x.
8
Mechanisms of physiological fibrinolysis.生理性纤维蛋白溶解机制。
Baillieres Clin Haematol. 1995 Jun;8(2):277-90. doi: 10.1016/s0950-3536(05)80268-9.
9
Fibrinolytic changes in a patient with toxic shock syndrome; release of active u-PA.中毒性休克综合征患者的纤溶变化;活性尿激酶型纤溶酶原激活物的释放
Intensive Care Med. 1998 Mar;24(3):258-61. doi: 10.1007/s001340050561.
10
Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.白天血浆中优球蛋白溶解时间、组织型纤溶酶原激活物以及游离和总纤溶酶原激活物抑制剂水平的波动情况。
Thromb Res. 1990 Jan 1;57(1):13-20. doi: 10.1016/0049-3848(90)90191-e.